Joan Stilling, MD
Physical Medicine & Rehabilitation · New York, NYNPI 1346845872
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 4 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 3 manufacturers reported payments, led by AbbVie at 36.7% of the total.
Across 4 payments — averaging $100.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$148
- Ipsen Biopharmaceuticals, Inc$136
- MML US, Inc.$119
Across 111 payments — averaging $2986.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ipsen Pharma SAS$199K
- Merz Pharmaceuticals, LLC$133K
What the payments were for
- Food & beverage$403100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 2 | $148 |
| Ipsen Biopharmaceuticals, Inc | 1 | $136 |
| MML US, Inc. | 1 | $119 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$403 in reported general payments places this provider in the 60th percentile of 872 physical medicine & rehabilitation providers in New York.
See all physical medicine & rehabilitation providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Baclofen | 22 | $1,024 |
| Gabapentin | 27 | $708 |
| Diclofenac Sodium | 11 | $135 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in New York
- Heidi FuscoNew York$153K
- Michael OdellNew York$67K
- Craig AntellNew York$65K
- Michael StubblefieldNew York$53K
- Heakyung KimNew York$53K
- Russell SilverNew York$34K
- Julia IafrateNew York$32K
- Neil JaseyNew York$29K
- Christian CustodioNew York$19K
- Karan JoharNew York$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.